Lv3
250 积分 2024-07-16 加入
Adhesion GPCR ADGRE2 Maintains Proteostasis to Promote Progression in Acute Myeloid Leukemia
1天前
已完结
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study
1天前
已完结
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
1天前
已完结
TP53 in MDS and AML: Biological and clinical advances
1天前
已完结
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
2天前
已完结
Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia
4天前
已完结
Targetable leukaemia dependency on noncanonical PI3Kγ signalling
5天前
已完结
Discovery of Potent and Selective PI3Kδ Inhibitors for the Treatment of Acute Myeloid Leukemia
5天前
已完结
Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium
5天前
已完结
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells
10天前
已完结
皖公网安备34019202002308
